ACRO’s new RBQM Summary Report highlights the key takeaways from ACRO’s RBQM survey, outlining the current state of RBM & RBQM in the clinical research industry.
ACRO’s RBQM Working Group published data from the third annual
landscape survey on how RBM & RBQM is being utilized in clinical trials.
Join us every Tuesday as we take a look at the current state of clinical research and what direction the industry must head in to continue improving trials for patients.
Get ACRO’s newsletter to stay informed about our work and the industry.
Data governance can mean different things across the #ClinicalResearch ecosystem, from executives concerned with ROI to sales teams leveraging details for revenue streams. @IQVIA_global discusses how data quality, trust, and compliance influence each goal. https://bit.ly/3GjKMAw
While #ClinicalTrials become more complex, patients and sites are faced with the risk of taking on more of this burden. This @Y_Prime eBook explores how organizations can create efficiencies, reduce complications, and ensure accurate data. https://bit.ly/49Y4n6L
A #ClinicalTrial that doesn't prioritize diversity and inclusion risks not adequately serving patients. @FlorenceHCare details the guidance from the FDA on the intersection between diversity and technology in the #ClinicalTrial world. Watch now: https://bit.ly/40ZURMp
#ClinicalTrial teams are not guaranteed the best results just by having top #technology. @PPDCRO explains how a sophisticated data strategy can unlock insights and leverage analytics — and shares three steps to getting there. Read them here: https://bit.ly/40XzGuD
WASHINGTON, DC – ACRO is pleased to announce the launch of its “Good Clinical Podcast.” The podcast brings together leaders in clinical…
WASHINGTON, DC – Washington DC – ACRO is pleased to announce that its Board of Directors has elected Paul Kirchgraber, M.D., Executive…
WASHINGTON, DC – Today, the Association of Clinical Research Organizations (ACRO)’s DCT Working Party releases the latest addition to its DCT Toolkit:…
Our member companies have faced widespread clinical trial disruptions in the past few years – from the global pandemic, to the war…
WASHINGTON, DC – This week, the Association of Clinical Research Organizations (ACRO)’s Diversity and Inclusion in Clinical Trials committee is proud to…
The below is an Op-Ed authored by ACRO Chair, Jackie Kent, for MedPage Today on August 6, 2022. Read the full article…
Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »
ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »
ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »
In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »
ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »
We help create a global regulatory and business environment
where ACRO members succeed
; 
